<- Go Home
Forte Biosciences, Inc.
Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
Market Cap
$76.7M
Volume
2.8K
Cash and Equivalents
$16.4M
EBITDA
-$35.6M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$28.68
52 Week Low
$4.11
Dividend
N/A
Price / Book Value
1.87
Price / Earnings
-0.65
Price / Tangible Book Value
1.87
Enterprise Value
$60.4M
Enterprise Value / EBITDA
-1.70
Operating Income
-$35.6M
Return on Equity
137.40%
Return on Assets
-67.66
Cash and Short Term Investments
$16.4M
Debt
N/A
Equity
$9.4M
Revenue
N/A
Unlevered FCF
-$18.4M
Sector
Biotechnology
Category
N/A